Related Funds
| Fund Name | Location |
| JMDC Japan | Japan, Tokyo |
| Line Moon Ventures | Atlanta, Georgia, United States |
| mHUB | Chicago, Illinois, United States |
| O Luxe Holdings | - |
| Perfect World | Beijing, Beijing, China |
| Power Financial Corporation | Canada, Ontario, Toronto |
| Reinhart Capital | - |
| Technology Associates Management | Plano, Texas, United States |
| Venture Leader Group | California, San Francisco, United States |
| Wells Fargo | California, San Diego, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Axuall | $20M | 31 May 2023 | Cleveland, Ohio, United States | ||
Eikon Therapeutics | $518M | 06 Jan 2022 | Hayward, California, United States | ||
Circle Pharma | $66M | 16 Jun 2021 | San Francisco, California, United States | ||
Janux Therapeutics | $125M | 20 Apr 2021 | La Jolla, California, United States | ||
A2 Biotherapeutics | $71M | 06 Oct 2020 | California, United States | ||
Surrozen | $50M | 15 Mar 2019 | South San Francisco, California, United States |
– Circle Pharma from South San Francisco develops macrocycle drug discovery and development company focused on intractable cancer targets.
– The company raised $66m in Series C financing.
– The round was co-led by The Column Group and Nextech Invest with participation from Pandect Bioventures, together with new investors including Euclidean Capital, Pavillion Capital, Hartford HealthCare Endowment and Eli Lilly and Company.
– The new investment will be used to advance its wholly owned cyclin-targeted programs towards the clinic.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Axuall | $20M | 31 May 2023 | Cleveland, Ohio, United States | ||
Eikon Therapeutics | $518M | 06 Jan 2022 | Hayward, California, United States | ||
Circle Pharma | $66M | 16 Jun 2021 | San Francisco, California, United States | ||
Janux Therapeutics | $125M | 20 Apr 2021 | La Jolla, California, United States | ||
A2 Biotherapeutics | $71M | 06 Oct 2020 | California, United States | ||
Surrozen | $50M | 15 Mar 2019 | South San Francisco, California, United States |
